CIK 0001787400
- Non-accelerated filer
- Smaller reporting company
Nkarta, Inc.
Sign in to watch- Ticker
- NKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474515206
- Phone
- +1 925-407-1049
- Business address
- 1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Sr. VP, Technical Operations sold 4,140 shares at $15.00 ($62,100)
- 4 Open-market buy Director bought 1,333,333 shares at $15.00 ($19,999,995)
- 4 Open-market buy Director bought 2,200,000 shares at $15.00 ($33,000,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 41,900 shares (grant or award)
- 4 Grant or award Mahmood Nadir acquired 12,800 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 12,800 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 12,800 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 12,800 shares (grant or award)
- 4 Grant or award Sr. VP, Technical Operations acquired 5,300 shares (grant or award)
- 4 Open-market sale Sr. VP, Technical Operations sold 4,140 shares at $15.64 ($64,750)
- 4 Open-market sale Chief Executive Officer sold 8,500 shares at an average $27.18 ($231,051)
- 4 Open-market sale Brandenberger Ralph sold 4,140 shares at $32.08 ($132,811)
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at $37.28 ($372,800)
- 4 Open-market sale Chief Scientific Officer sold 3,600 shares at $31.53 ($113,508)
Page 7 of 11 · 218 filings